Clinical trials
Pleural Effusion trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 4 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Oxford | 5 |
| Oxford University Hospitals NHS Trust | 2 |
| Amgen | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| Johns Hopkins University | 1 |
| King's College Hospital NHS Trust | 1 |
| Norfolk and Norwich University Hospitals NHS Foundation Trust | 1 |
| Northumbria Healthcare NHS Foundation Trust | 1 |
| Portsmouth Hospitals NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pleural Effusion | 18 |
| Pleural Effusion, Malignant | 4 |
| Pneumothorax | 3 |
| Ascites | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Pleural Diseases | 2 |
| Anemia | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.